Shanghai HeartCare Medical Technology (HKSE:06609) Long-Term Capital Lease Obligation : HK$34.4 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Long-Term Capital Lease Obligation?

Shanghai HeartCare Medical Technology's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$34.4 Mil.

Shanghai HeartCare Medical Technology's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$44.5 Mil) to Jun. 2023 (HK$41.4 Mil) and declined from Jun. 2023 (HK$41.4 Mil) to Dec. 2023 (HK$34.4 Mil).

Shanghai HeartCare Medical Technology's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$48.3 Mil) to Dec. 2022 (HK$44.5 Mil) and declined from Dec. 2022 (HK$44.5 Mil) to Dec. 2023 (HK$34.4 Mil).

Shanghai HeartCare Medical Technology Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Long-Term Capital Lease Obligation Chart

Shanghai HeartCare Medical Technology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

0.15

28.99

48.31

44.46

34.42

Shanghai HeartCare Medical Technology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial				48.31	44.61	44.46	41.40	34.42

Shanghai HeartCare Medical Technology (HKSE:06609) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shanghai HeartCare Medical Technology Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN

Website

http://www.strokemedical.com

Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.

Executives

Ding Kui	2201 Interest of corporation controlled by you
Wisary Limited	2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines